Towards a genetic AIDS vaccine

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Boosted Hope — AIDS Vaccine Research

Medical and Scientific Advisory Committee Bisher Akil, M.D. Peter Anton, M.D. H. Aaron Aronow, M.D. Victor Beer, M.D. Aron Bick, M.D. Joseph Church, M.D. Gary Cohan, M.D. Richard Cooper, M.D. Jim Corti, R.N. George Fareed, M.D. Erik Fleishman, D.O. Jonathan Goldsmith, M.D. Michael Gottlieb, M.D. Edward Grant, M.D. David Hardy, M.D. David Hart, M.D. Scott Hitt, M.D. John James Wilbert Jordan, M....

متن کامل

Prospects for an AIDS vaccine.

Acquired immunodeficiency syndrome (AIDS) was first identified at the end of 1981.1 In 1983, the causative virus, human immunodeficiency virus (HIV-1), was identified2, almost certainly having entered humans from a reservoir in chimpanzees, possibly on several occasions.3 Since 1981 the virus has spread to cause possibly the most serious epidemic infection in human history. The virus has divers...

متن کامل

Progress towards a Leishmania vaccine.

Leishmaniasis is a vector-born protozoan disease. Approximately 12 million individuals are affected worldwide with an estimated annual incidence of 1.5-2 million. Two clinical manifestations are recognized, cutaneous, and visceral, both of which are common in the Middle East. In both forms, infection is chronic, with potential deformities, persistence following cure, and lifelong risk of reacti...

متن کامل

HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development

Acquired Immunodeficiency Syndrome (AIDS) is one of the most critically acclaimed endemic diseases, caused by two lentiviruses HIV-1 and 2. HIV-2 displays intimate serological and antigenic resemblance to Simian Immunodeficiency Virus (SIV) along with less pathogenicity, lower infectivity and appreciable cross reactivity with HIV-1 antigens. The present era is confronted with the challenge to f...

متن کامل

Towards an AIDS vaccine: the transmembrane envelope protein as target for broadly neutralizing antibodies.

Although the development of an effective vaccine is the main goal in the fight against AIDS, all attempts by numerous laboratories to develop a vaccine have failed so far. In addition, it is still unclear whether cytotoxic T cells or neutralizing antibodies or both should be induced. The major advantage of neutralizing antibodies is their ability to prevent infection and subsequent integration ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Retrovirology

سال: 2009

ISSN: 1742-4690

DOI: 10.1186/1742-4690-6-93